Assessment of POC CD4 Detecting Mode in District or County Labs — Jiangsu Province, China, 2021-Reference-Cited by-同舟云学术

Assessment of POC CD4 Detecting Mode in District or County Labs — Jiangsu Province, China, 2021

Published:2022 Issue:47 Volume:4 Page:1059-1065
ISSN:2096-7071
Container-title:China CDC Weekly
language:en
Short-container-title:

Author:

Zhang Zhi, ,Xu Xiaoqin,Sun Chengqing,Lu Jing,Hu Haiyang,Zhou Ying,Fu Gengfeng,

Publisher

Chinese Center for Disease Control and Prevention

Subject

Public Health, Environmental and Occupational Health,Infectious Diseases,Epidemiology

Link

https://weekly.chinacdc.cn/en/article/pdf/preview/10.46234/ccdcw2022.213

Reference15 articles.

1. Martin TCS, Abrams M, Anderson C, Little SJ. Rapid antiretroviral therapy among individuals with acute and early HIV. Clin Infect Dis 2021;73(1):130 − 3. http://dx.doi.org/10.1093/cid/ciaa1174.

2. AIDS and Hepatitis C Professional Group, Society of Infectious Diseases, Chinese Medical Association, Chinese Center for Disease Control and Prevention. Chinese guidelines for diagnosis and treatment of HIV/AIDS (2021 edition). Chin J Int Med 2021;60(12):1106 − 28. http://dx.doi.org/10.3760/cma.j.cn112138-20211006-00676. (In Chinese).

3. Lu HY, Wu H, Zhao H, Song SJ, Ji YX, Sun WD, et al. Comparison of CD₄⁺ lymphocyte counts measured by two types of flow cytometer: BD FACS Calibur and Beckman Coulter FC500. Chin J AIDS STD 2008;14(4):327-9. https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFD&dbname=CJFD2008&filename=XBYA200804003. (In Chinese).

4. Zhang YL, Zheng HC, Wei XL, Zhang HL, Yang Y, Zhao X. Effects of highly active anti-retroviral therapy (HAART) on T lymphocyte activation and CD4⁺CD45RA⁺ T cell subsets in HIV/AIDS patients. Chin J Microbiol Immunol 2020;40(7):518 − 22. http://dx.doi.org/10.3760/cma.j.cn112309-20200106-00008. (In Chinese).

5. Lu XF, Sun HX, Li HC, Xia W, Wu H, Chen DH, et al. Validation of the BD FACSPresto system for the measurement of CD4 T-lymphocytes and hemoglobin concentration in HIV-negative and HIV-positive subjects. Sci Rep 2020;10(1):19605. http://dx.doi.org/10.1038/s41598-020-76549-6.